WEight loss in young obese subjects improves lipids and adipokines levels and reduces arterial stiffness

Acta Endocrinologica

Volumn 9, Issue 1, 2013, Pages 79-86

  Elian, Viviana Iulia ^a   Cucu, I ^b   Cheta, D ^a,b   Serafinceanu, C ^a,b  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b 'Prof NC Paulescu' National Institute of Diabetes Nutrition and Metabolic Diseases   (Romania)

Author keywords

Adipokines; Lifestyle intervention; Obesity; Stiffness

Indexed keywords

EID: 84876082359     PISSN: 18410987     EISSN: None     Source Type: Journal    
DOI: 10.4183/aeb.2013.79     Document Type: Article

References (29)

1. WHO: Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. Geneva, WHO Technical Report Series 894, 2000.
2. James WP: The epidemiology of obesity: the size of the problem. J. Internal Med. 2008; 263:336-352.
3. Valean C, Tatar S, Nanulescu M, Leucuta A, Ichim G. Prevalence of Obesity and Overweight Among School Children in Cluj-Napoca. Acta Endocrinol-Buc 2009; 5(2):213-219.
4. Emandi AC, Puiu M, Gafencu M, Pienar C. Growth References for School Aged Children in Western Romania. Acta Endocrinol-Buc 2012; 8(1):133-151.
5. Tsigosa C, Hainerb V, Basdevantc A, Finerd N, Friede M, Mathus-Vliegenf E, Micicg D, Maislosh M, Roman G, Schutzj Y, Toplakk H, Zahorska-Markiewiczl B; for the Obesity Management Task Force of the European Association for the Study of Obesity Management of Obesity in Adults: European Clinical Practice Guidelines Obesity Facts 2008;1:106-116
6. Oros S, Ianas O, Vladoiu S, Giurcaneanu M, Ionescu L, Neacsu E, Voicu G, Stoiceanu M, Rosca R, Neamtu C, Badiu C, Dumitrache C. Does Obesity Protect Postmenopausal Women Against Osteoporosis? Acta Endocrinol-Buc 2012; 8(1):67-76.
7. Lichiardopol R, Florentiu A, Radoi V. Body Composition and the Metabolic Impact of Weight Excess in Patients with Type 1 and Type 2 Diabetes Mellitus. Acta Endocrinol-Buc 2010; 6(4):493-506.
8. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation. 2002;106:2533-2536.
9. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology and therapy of arterial stiffness Artherioscl, Thromb and Vasc Biol 2005, 25: 932-943.
10. Konstantinides S, Schafer K, Loskutoff DJ. The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity. Ann N Y Acad Sci 2001; 947:134-141.
11. Iordache N, Copaescu C, Litescu M, Munteanu R, Boru C, Badiu C, Stoica A. Bariatric surgery evolution in Romania results 1 year after a variety of bariatric procedures. Acta Endocrinol-Buc 2008; 4(2):161-172.
12. Balkestein EJ, van Aggel-Leijssen DP, van Baak MA, Struijker-Boudier HA, Van Bortel LM. The effect of weight loss with or without exercise training on large artery compliance in healthy obese men. J Hypertens 1999; 17(12 Pt 2):1831-1835.
13. Aucott L, Poobalan A, Smith WC, Avenell A, Jung R, Broom J. Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review. Hypertension 2005; 45(6):1035-1041.
14. Dengo AL, Dennis EA, Orr JS, Marinik EL, Ehrlich E, Davy BM, Davy KP. Arterial destiffening with weight loss in overweight and obese middle-aged and older adults. Hypertension 2010; 55(4):855-861.
15. US Department of Health and Human Services. Dietary Guidelines for Americans 2005. 6th ed. Washington, DC: US Department of Agriculture; 2005.
16. "STEPwise approach to surveillance (STEPS)". World Health Organization. Retrieved March 21, 2012.
17. Cooper JN, Buchanich JM, Youk A, Brooks MM, Barinas-Mitchell E, Conroy MB, Sutton-Tyrrell K. Reductions in arterial stiffness with weight loss in overweight and obese young adults: potential mechanisms. Atherosclerosis 2012; 223(2):485-490.
18. Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T, Miyashita Y, Saiki A, Takahashi M, Suzuki K, Takata M. Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb 2011; 18(11):924-938.
19. Satoh N, Shimatsu A, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Ooishi M, Kotani K, Ogawa Y. Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome. Hypertens Res 2008; 31(10):1921-1930.
20. Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, Humphrey LL. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151(7):496-507.
21. Pop D, Zdrenghea D, Stanca L, Bodisz G, Petrovai D, Borz B. Adiponectin and Leptin Levels Correlate with Body Mass Index and Lipid Fractions But Not with Disturbances of Glucose Metabolism. Acta Endocrinol-Buc 2009; 5(3):329-335.
22. Valean C, Ichim G, Tatar S, Samasca G, Leucuta A, Nanulescu M. Prevalence of Metabolic Syndrome and Serum Profile of Adipokines (Leptin and Adiponectin) in Children with Overweight Or Obesity. Acta Endocrinol-Buc 2010; 6(3):343-354.
23. Coppola A, Marfella R, Coppola L, Tagliamonte E, Fontana D, Liguori E, Cirillo T, Cafiero M, Natale S, Astarita C. Effect of weight loss on coronary circulation and adiponectin levels in obese women. Int J Cardiol. 2009;134(3):414-416.
24. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289(14):1799-1804.
25. Blüher M, Rudich A, Klöting N, Golan R, Henkin Y, Rubin E, Schwarzfuchs D, Gepner Y, Stampfer MJ, Fiedler M, Thiery J, Stumvoll M, Shai I. Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 2012;35(2):342-349.
26. Holm JC, Gamborg M, Ward LC, Gammeltoft S, Kaas-Ibsen K, Heitmann BL, Sørensen TI. Tracking of leptin, soluble leptin receptor, and the free leptin index during weight loss and regain in children. Obesity Facts. 2011;4(6):461-468.
27. Klempel MC, Varady KA. Reliability of leptin, but not adiponectin, as a biomarker for diet-induced weight loss in humans. Nutrition Review. 2011;69(3):145-154.
28. Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia. Endocrinol Metab Clin North Am. 2003;32(4):855-867.
29. Park KG, Park KS, Kim MJ, Kim HS, Suh YS, Ahn JD, Park KK, Chang YC, Lee IK. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diab Res Clin Pract. 2004;63(2):135-142.